pembrolizumabbevacizumab-naïvebevacizumab-refractorydexamethasonebevacizumabmelanomarGBM
…cyte count (ALC) identifies a subgroup unlikely to benefit from pembrolizumab.Methods We performed a single-center retrospective study of adu…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: bevacizumab-refractory ×
bevacizumab-refractory
This drug is selected. Its supporting articles are shown below.